Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $8449.0.

  • Cumberland Pharmaceuticals' Change in Intangibles fell 7403.18% to $8449.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $65086.0, marking a year-over-year decrease of 4865.86%. This contributed to the annual value of $113253.0 for FY2024, which is 3407.21% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Change in Intangibles is $8449.0, which was down 7403.18% from $13912.0 recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Change in Intangibles peaked at $1.8 million during Q4 2022, and registered a low of $8449.0 during Q3 2025.
  • Moreover, its 5-year median value for Change in Intangibles was $35336.0 (2022), whereas its average is $134115.2.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Change in Intangibles surged by 245173.0% in 2022 and then plummeted by 9787.97% in 2023.
  • Cumberland Pharmaceuticals' Change in Intangibles (Quarter) stood at $70317.0 in 2021, then soared by 2451.73% to $1.8 million in 2022, then tumbled by 97.88% to $38044.0 in 2023, then crashed by 35.53% to $24526.0 in 2024, then plummeted by 65.55% to $8449.0 in 2025.
  • Its Change in Intangibles stands at $8449.0 for Q3 2025, versus $13912.0 for Q2 2025 and $18199.0 for Q1 2025.